The 3<sup>rd</sup> International Conference on Drug Discovery & Therapy: Dubai, February 7 - 11, 2011

TENTATIVE PROGRAM


DAY 1: Monday, February 18, 2013

5th International Conference on

Drug Discovery & Therapy

February 18–21, 2013, Dubai Women's College, Dubai, UAE

www.icddt.com

 

TIME. 10:00 a.m.

INAUGURAL PROGRAM

 

COFFEE BREAK: 11:00 – 11:45 a.m.

JOINT PLENARY SESSION

Time

Chairman: F. Murad

Co-Chairman: R.L. Atkinson

Speaker

Title

11:45

12:30
p.m.

Location: Auditorium

Hartmut Michel

(Nobel Laureate)

PL

 

Membrane Proteins: Importance, Structures, Functions

12:30

1:00
p.m.

Location: Auditorium

Talal Al Zaher

JL 

 

Gulf Pharmaceutical Industries (Julphar) from Pharmaceutics to Biopharmaceutics

LUNCH BREAK: 1:00 – 1:45 p.m.

Locations

Lecture Hall 6

Room B-1008

Ground Floor: Health Science Building

Lecture Hall 2

MPH 2

Top Floor: Health Science Building

 

Lecture Hall 3

MPH 3

Top Floor: Health Science Building

Lecture Hall 4

MPH 4

Top Floor: Health Science Building

Lecture Hall 5

Room B-1001

Ground Floor: Health Science Building

Lecture Hall 1

MPH 1

Top Floor: Health Science Building

 

Chairman: G. Muller

Co-Chairman: E.G. Skurikhin

Chairman: R.L. Atkinson

Co-Chairman: J.W. Lillard, Jr.

Chairman: F.-M. Werner

Co-Chairman: Z. Al-Mohsen

Chairman: Y. Komarova

Co-Chairman: T. Neumann

Chairman: A. Yu

Co-Chairman: F. Gansauge

Chairman: A.S. el Baghdady

Co-Chairman: R. Chaguturu

 

1:45

2:05

p.m.

Vladimir N. Smirnov

SL

Human Allogeneic Ab0/rh-identical Umbillical Cord Blood Cells in the Treatment of Juvenile Patients with Cerebral Palsy

1:45

2:15

p.m.

Subrata Chakrabarti

IL

MicroRNA Based Therapeutics in Diabetic Vascular Complications

 

 

1:45

2:15

p.m.

Sasa Kenjeres

IL

Computer Simulations Based Optimization of Magnetic Drug Targeting and Delivery in Patient Specific Vascular Geometries

1:45

2:15

p.m.

Dipak P. Ramji

IL

Regulation of Macrophage Foam Cell Formation by Cytokines

 

1:45

2:15

p.m.

Yi Sun

IL

Targeting Cullin-RING Ligases by MLN4924 for Novel Anti-cancer Therapy

1:45

2:15

p.m.

Robert Craig Deininger

IL

Translational Research Institute Bench to Bedside Success

 

 

2:05

2:25

p.m.

Galina Pavlova

SL

Protective and Trophic Properties of GDNF and its Modifications for Cells

2:15

2:35

p.m.

Asna Urooj

SL

Medicinal Plants: Possible Mechanisms of Antihyperglycemic Action

2:15

2:35

p.m.

Costas Kiparissides

SL

Nanocarrier-based Mucosal Delivery of Macromolecular Drugs and Antigens

 

2:15

2:45

p.m.

Paolo Brunamonti Binello

IL

Management of Coagulation's Disorders in Oral Surgery: State of Art

 

2:15

2:45

p.m.

Noboru Hattori

IL

Host Plasminogen Activator Inhibitor-1 Plays a Determinant Role in Tumor Progression and Angiogenesis: Proposal of an Antitumor Therapy Targeting the Host-derived Factor

 

2:15

3:15 p.m.

Rathnam Chaguturu

IL

Open Innovation-based Drug Discovery: A Promising Precompetitive Paradigm

 

2:25

2:45

p.m.

John Yu

SL

Harnessing Novel Biomarkers of Human Embryonic Stem Cells for Cancer Diagnosis and Therapy

2:35

2:55

p.m.

Syed K. Goda

SL

Isolation and Structural Determination of Two Novel Compounds for the Control of Diabetes Mellitus and Obesity

 

2:35

2:55

p.m.

Ayman Allahham

SL

Agglomerate Strength Distributions for Understanding the Influence of Poorly Water Soluble Agglomerate Modifiers on the Dissolution of Indomethacin from Interactive Mixtures

2:45

3:05

p.m.

Moses Kayode Omole

SL

A Ten Year Study of Management of Ischemic Heart Disease in a Tertiary Hospital in South West Nigeria

2:45

3:15

p.m.

Mary Bebawy

IL

Microparticle-mediated Transfer of Drug Efflux Transporters Confers Cancer Multidrug Resistance

 

Withdraw

3:15

3:45

p.m.

Ibis Sแnchez-Serrano

IL

The Core Model: Drug discovery and development via effective translational science and public-private collaboration

2:45

3:05

p.m.

Piotr Rieske

SL

SOX2 Reprograms Fibroblasts in to the Induced Stem Cells

 

 

 

2:55

3:25

p.m.

Fatima Z. Basha

IL

Design, Discovery, and Synthesis of Novel DPP-IV Inhibitors as Potential Anti-diabetic Agents

 

2:55

3:15

p.m.

Mikhail V. Khvostov

SL

Arabinogalactan is the Tool for Improvement Bioavailability and Toxicity of Drugs

 

 

3:05

3:25

p.m.

Quadiri Timour

SL

Protective Effects of Ranolazine and Propranolol, alone or Combined, on the Structural and Functional Alterations of Cardiomyocyte Mitochondria in a Pig Model of Ischemia/Reperfusion

 

3:15

3:45

p.m.

Fazlul Huq

IL-25

Phytochemicals as a Rich Source of Tumour Active Compounds for Combination with Targeted Therapy Towards Overcoming Drug Resistance in Cancer

 

3:45

4:15

p.m.

Assem S. el Baghdady

IL

Successful collaboration between Academia and the pharmaceutical industry : A Dream or Reality?

3:05

3:25

p.m.

Costas Kiparissides

SL

CFD Simulation of a Dry Powder Inhaler and Particles Deposition in the Respiratory Tract

 

 

3:25

3:45

p.m.

R.D. Lele

SL

Osmotin (Plant Analog of Adiponection): As a Therapeutic Agents

3:15

3:35

p.m.

Rana Bakhaiaer

SL

Gene Expression Modeling of Cause and Effect Relationships in Nanoparticle Formulation

 

 

3:25

3:45

p.m.

Inkyeom Kim

SL

Histone Deacetylase Inhibition Abolishes Development of Hypertension Through Inhibition of Minealocorticoid Receptor Transactivation in DOCA-Induced Hypertensive Rats

3:45

4:15

p.m.

Rakesh Kumar

IL

Revealing an Essential Modifying Role of a Master Coregulator in Promoting Breast-to-lung Metastasis

 

4:15

4:45

p.m.

Thomas D.Y. Chung

IL

Partnering with Governmental Programs/Agencies and Pharmaceutical/Biotechnology Companies to Find New Medicines

3:25

3:45

p.m.

Y. El-Obedi

SL

Title Awaited

 

3:45

4:05

p.m.

Aishah Adam

SL

Reducing Pathogenicity in Type 2 Diabetes Mellitus (T2DM) by Targeting Oxidative Stress

3:35

3:55

p.m.

Wael M. Rabeh

SL

Correction of the Misfolded Cystic Fibrosis Transmembrane  Conductance Regulator Channel is a Two-step Process

3:45

4:05

p.m.

Shadab A. Siddiqi

SL

A Novel Cell Biological Approach to Control Hyperlipidemia

4:15

4:35

p.m.

B. Rihova

SL

Therapy-dependent Induct on of Systemic Anticancer Immune Response by Nanotherapeutics

 

4:45

5:15

p.m.

Bhushan Patwardhan

IL

A pharmacognosy perspective for innovations in forging drug discovery partnerships

 

4:05

4:25

p.m.

Brett A. Premack

SL

Leukotriene A4 Hydrolase as a Novel Drug Target in Pulmonary Inflammation

3:55

4:25

p.m

Hideaki Itoh

IL

70-kDa Molecular Chaperone HSP70 is a Direct Target of Antibiotic Gentamicin

 

4:05

4:25

p.m.

Adrian Angel Inchauspe

SL

Sudden, Predictable and Preventable Death in Pharmacological Cardio Safety

 

4:35

4:55

p.m.

Rahila Najam

SL

Comparative Metabolic Toxicity in Patients of Advanced Colorectal Carcinoma Treated with Different Schedules of FOLFOX

 

 

4:25

4:45

p.m.

 

Dermot Cox

SL

FcyRlla: A Novel Drug Target in Infection and Inflammation

4:25

4:45

p.m.

Muhammad Yusha'u

SL

Anti-Malarial Activity of Cassia Sieberiana Leaf Extracts

4:25

4:45

p.m.

Ashour Eljamil

SL

Cholesterol and Diet

 

 

Social Mixer: 4:55 p.m. – 6:00 p.m.

The buses will leave for hotels at 6:05 p.m.

 

[Back To Top]

DAY 2: Tuesday, February 19, 2013

JOINT PLENARY SESSION

Time

Chairman: H. Michel

Co-Chairman: Atta-ur-Rahman

 

Speaker

Title

9:00

9:45

a.m.

Location: Auditorium

Ferid Murad (Nobel Laureate)

PL

Discovery of Nitric Oxide and Cyclic GMP Cell Signaling and Their Role in Drug Development

9:45

10:30

a.m.

Location: Auditorium

Jean-Marie Lehn (Nobel Laureate)

PL

From Supramolecular Chemistry Towards Adaptive Chemistry Bioorganic and Drug Discovery Aspects

 

COFFEE BREAK: 10:30 – 11:00 a.m.

Locations

Lecture Hall 1

MPH 1

Top Floor: Health Science Building

Lecture Hall 2

MPH 2

Top Floor: Health Science Building

Lecture Hall 3

MPH 3

Top Floor: Health Science Building

Lecture Hall 4

MPH 4

Top Floor: Health Science Building

Lecture Hall 5

Room B 1001

Ground Floor: Health Science Building

 

Chairman:  D.K. Lahiri

Co-Chairman: H.C. Pant

Chairman: F.Z. Basha

Co-Chairman:  S.  Kenjeres

 

 

Chairman: K. Jackowski

Co-Chairman: C.  Carfagna

Chairman: T. Baum

Co-Chairman: K. Yoshizaki

 

Chairman:  N.  Hattori

Co-Chairman: Y.  Sun

11:00

11:30

a.m.

Aurora Martinez

IL

Screening and Evaluation of Pharmacological Chaperones for Tyrosine Hydroxylase; Correction of Neurotransmitter Deficiencies

11:00

11:30

a.m.

Thomas Neumann

IL

High Throughput Fragment Based Drug Discovery by SPR Imaging of Chemical Microarrays

 

11:00

11:30

 a.m.

Asier Unciti-Broceta

IL

BOOM Therapy Strategy – Spatially-Controlled Prodrug Activation Mediated by Engineered Pd-Containing Devices

11:00

11:30

 a.m.

James W. Lillard, Jr.

IL

ANTI-CXCL 13 Antibody Therapy for Advanced Metastatic Prostate Cancer

 

11:00

11:30

 a.m.

Michael C. Pirrung

IL

Synthesis and Biology of Natural Proteasome-inhibiting Anticancer Agents

 

11:30

12:00

noon

W. Gibson Wood

IL

Statins and Neuroprotection: Simvastatin-induced Upregulation of Bcl-2 In vivo and In vitro

 

11:30

11:50

a.m.

Vaishali Anil Kilor

SL

Design and Development of Novel Microemulsion Based Topical Formulation of Hesperidin

11:30

12:00

noon

Masahiko Seki

IL

An Efficient Catalytic System for C-H Activation: A Novel and Practical Synthesis of Angiotensin II Receptor Blockers

 

11:30

11:50

a.m.

Tse Wen Chang

SL

The Combination of Anti-IgE Therapy and Specific Immunotherapy for the Treatment of Allergic Diseases

 

11:30

11:50

a.m.

Krishna P. Gupta

SL

Synergistic Effects of Combination of Compounds in Controlling the Tumor Development: Involvement of the Regulators of Tumorigenesis

 

 

 

 

12:00

12:30

p.m.

Masashi Sakai

IL

Synaptic Mechanism in the Primary Auditory Cortex (AI) Underlying Voice-Onset Time (VOT) Dependent Categorical Perception: Relevance to Language Specific Language Impairment (SLI)

 

11:50

12:10

p.m.

Adrian Angel Inchauspe

SL

Risk Management Project Applied to Torsadogenic Index

 

12:00

12:30

p.m.

Johan Van der Eycken

IL

A Modular Approach to Chiral Imidates: A New Class of Nitrogen-Based Chiral Ligands as Tools for Medicinal Chemistry

11:50

12:20

p.m.

Piero Procacci

IL

Characterization and Optimization of Tartrate-based Tumor Necrosis Factor-alpha Converting Enzyme Inhibitors

11:50

12:10

p.m.

Sayed K. Goda

SL

Production of Novel Glucarpidases for More Efficient Cancer Treatment and Detoxification of Drugs

 

 

12:30

12:50

p.m.

Youssef Sari

SL

MS-153, A Synthetic GLT1 Activator, Attenuates Ethanol Intake in Alcohol Preferring Male Rats

 

12:10

12:30

p.m.

Subrata Chakrabarti

SL

Accelerated Wound Healing Using miRNA Antagomirs in Normal and in Diabetic Conditions

 

 

12:30

12:50

p.m.

Muhammad Naeem Khan

SL

Thiochromenopyridines-II: Antibacterial and antioxidant 9-benzylideneamino-5H-thiochromeno[2,3-b] pyridine-5-ones

12:20

12:40

p.m.

Afaf Al Nadaf

SL

In Silico Search Culminate the Discovery of Low Micromolar β-Secretase Inhibitors

12:10

12:30

p.m.

Preeyanat Vongchan

SL

Thai Medicinal Plant Extract "Hing-Hai" Inhibited Adhesion of Colon Cancer Cell Line, SW 620

 

12:50

1:10

p.m.

Krzysztof Jozwiak

SL

Novel Positive Allosteric Modulators of the Human α7 Nicotinic Receptor Modulate the Antidepressant Activity Elicited by Nicotine

 

12:30

12:50

p.m.

Rafi Abd Al-Majeed Al-Razzuqi

SL

Is Glucosamine-chondroitin Risky to Normoglycemic Individuals with Family History of Diabetes Mellitus

 

12:50

1:10

p.m.

 

Sadiq G. Uthman

SL

How Birth Interval and Antenatal Care Affects Postpartum Haemorrhage Prevention in Maiduguri, Nigeria: A Study of Misopristol and Oxytocin

 

12:40

1:00

p.m.

 

Mohamed A. Morsy

SL

Protective Effects of Curcumin Against Indomethacin-induced Gastric Ulcer in Rats: Role of iNOS, NF-κB, and caspase 3

12:30

1:00

p.m.

Alice I. Yu

IL

Glycan-targeted Cancer Immunotherapy

 

 

 

12:50

1:10

p.m.

R. Perumal Samy

SL

Cationic and Hydrophobic Peptides as Powerful Antibacterial and Wound Healing Agents

 

1:00

1:20

p.m.

Mohamed Magdi

SL

Appraisal of Histone Deacetylase Inhibitors as Possible Cure for Breast Cancer

LUNCH BREAK: 1:10 – 2:00 p.m.

Locations

Lecture Hall 1

MPH 1

Top Floor: Health Science Building

Lecture Hall 2

MPH 2

Top Floor: Health Science Building

Lecture Hall 3

MPH 3

Top Floor: Health Science Building

Lecture Hall 4

MPH 4

Top Floor: Health Science Building

Lecture Hall 5

Room B 1001

Ground Floor: Health Science Building

 

Chairman:  M.  Sakai

Co-Chairman:  Y. Sari

Chairman:  S.M. Lee

Co-Chairman:  M.S. Sharifi

Chairman:  A.U. Broceta

Co-Chairman:  J.V. Eycken

Chairman: A. Khalid

Co-Chairman: K. Jozwiak

 

Chairman: M. Bebawy

Co-Chairman: F. Huq

2:00

2:30

p.m.

Julianna Kardos

IL

Therapeutic Potential of Neuro-glia Coupling in Epilepsy

2:00

2:30

p.m.

Brydon Lawrence Bennett

IL

Advantages and Challenges of Targeting Signal Transduction Pathways for Therapeutic Intervention

 

2:00

2:20

p.m.

Karol Jackowski

SL

Multinuclear MR Spectroscopy in the Gas Phase

2:00

2:30

p.m.

Thomas Baum

IL

Trabecular Bone Structure Analysis of the Spine Using Clinical Multi-detector Computed Tomography: Can it Predict Vertebral Bone Strength?

 

2:00

2:30

p.m.

Frank Gansauge

IL

Effectivity of Long Antigen Exposition Dendritic Cell Therapy (LANEX-DC)ฎ in the Palliative Treatment of Pancreatic Cancer

 

2:30

3:00

p.m.

Harish C. Pant

IL

A Novel Approach to Inhibit the Deregulation of the Kinases Involved in Neurodegenerative Diseases

 

2:30

3:00

p.m.

Michael G. Katze

IL

Systems Biology and Viral Diseases: New Strategies for Identifying and Evaluating Signatures, Targets, and Drugs

2:20

2:40

p.m.

Cosimo Carfagna

SL

Mediterranean Diet and Polymer Technology

2:30

3:00

p.m.

David L. Brody

IL

Advanced MRI Assessments of Brain White Matter Injury: Quantitative Radiological – Pathological Correlations and Development of Imaging-based Pharmacodynamic Strategies

2:30

3:00

p.m.

Riyaz Basha

IL

Strategies to Improve Therapeutic Responses in Treating Cancer

 

3:00

3:20

p.m.

Janos Szolcsanyi

SL

Transient Receptor Potentials of Trpv1 and Trpa1 as Targets for Analgesics on Nociceptors

3:00

3:30

p.m.

Tse Wen Chang

IL

Updates on Omalizumab and Anti-Cemx – Antibodies Targeting the IgE Pathway

 

2:40

3:00

p.m.

Amina A. Soayed

SL

Spectral, Thermal and Biological Studies on Transition Metal Complexes of Moxifloxacin – Imidazole mixed Ligands

 

3:00

3:20

p.m.

Dipak Maity

SL

Superparamagnetic Iron Oxide Nanoparticles for Magnetic Resonance Imaging (MRI) Application

3:00

3:30

p.m.

Q. Jane Wang

IL

PKD Small Molecule Inhibitors: Discovery, Development and Therapeutic Potential

 

3:20

3:40

p.m.

Ornella Corazza

SL

New Psychostimulant Agents Abuse

 

3:30

3:50

p.m.

Arjun Surya

SL

Small Molecule Modulators of the Kynurenin Pathway

3:00

3:20

p.m.

Abdollah Javidan

SL

Asymmetric Synthesis of New Spiro-oxindolopyrrolizidines

3:20

3:40

p.m.

 

Muhammad Sohaib

SL

A New Infection Imaging Agent Tc-99m Ceftriaxone: Labeling and Bio-distribution in Animal Models

3:30

3:50

p.m.

Dorly de Freitas Buchi

SL

Pre-clinical Results With a Highly Diluted Natural Complex, M1, as a Biologic Response Modifier Against Melanoma

 

 

 

 

 

 

3:40

4:00

p.m.

Zeibun Ramtoola

SL

Octa-arginine modified PLGA nanoparticles enhances loperamide delivery to the brain

 

 

 

3:50

4:10

p.m.

Quadiri Timour

SL

Protective Effects of Ranolazine and Propranolol, alone or Combined, on the Structural and Functional Alterations of Cardiomyocyte Mitochondria in a Pig Model of Ischemia/Reperfusion

 

3:20

3:40

p.m.

Hadariah Bahron

SL

Schiff Base Derived from m-phenylenediamine and o-vanillin and its Dimeric Dinuclear and Tetranuclear Co(II) and Zn(II) Complexes: Physicochemical and Antimicrobial Studies

3:40

4:00

p.m.

 

Zainab Al-Mohsen

SL

Attending to Women's Sexual Health in Bahrain: Does Physician's Gender Make a Difference?

 

3:50

4:10

p.m.

V. Badireenath Konkimalla

SL

Molecular Modelling Approaches and Chemogenomic Profiling of Naturally Occurring Compound as Potential EGFR-TK inhibitor

 

3:40

4:00

p.m.

Azita  Azarkeivan

SL

Evaluation of gastric side effects of new form of deferiprone (Entric coated) in patients with Thalassemia

 

 

 

Coffee Break / Posters Session: 4:00 – 4:50 p.m.

Shopping Visit: The buses will leave at 5:00 p.m.

 

[Back To Top]

DAY 3: Wednesday, February 20, 2013

JOINT PLENARY SESSION

Time

Chairman: M.I. Choudhary

Co-Chairman: D.K. Lahiri

Speaker

Title

9:00

9:45

a.m.

Location: Auditorium

Richard Lee Atkinson

PL

Role of Adenovirus 36 in Obesity, Diabetes, and Breast Cancer: Potential Treatment and Prevention Options

 

9:45

10:30

a.m.

Location: Auditorium

Goverdhan Mehta

PL

Revisiting Natural Products Chemistry: Synergy with Synthesis to Enhance Nature for Human Health and Wellbeing

COFFEE BREAK: 10:30 – 11:00 a.m.

Locations

Lecture Hall 1

MPH 1

Top Floor: Health Science Building

Lecture Hall 2

MPH 2

Top Floor: Health Science Building

Lecture Hall 3

MPH 3

Top Floor: Health Science Building

Lecture Hall 4

MPH 4

Top Floor: Health Science Building

 

Chairman:  A. Martinez

Co-Chairman:  J.  Kardos

Chairman:  A. Khalid

Co-Chairman:  V.A. Kilor

Chairman:  B.L. Bennett

Co-Chairman: M.G. Katze

Chairman:  J.-P. Renaud

Co-Chairman: A. Kopylov

11:00

11:20

a.m.

Krzysztof Jozwiak

SL

New Derivatives of Fenoterol: A Versatile Tool to Stimulate the β2 Adrenergic Receptor with Novel Therapeutic Perspectives

 

11:00

11:20

a.m.

Sergazy Mynzhasarovich Adekenov

SL

Multidimensional Study of Endemic Plant Species – Sources of New Medicinal Substances

 

11:00

11:30

a.m.

Jose Freire

IL

Differential Anti-Inflammatory Activity of Glucocorticoid and PDE 4 Inhibitors on Neutrophils from COPD and Non-COPD Subjects

11:00

11:30

a.m.

Aung Naing

IL

A Personalized, Pathway Specific Targeted Strategies for Solid Tumors

 

11:20

11:40

a.m.

Vidya Gopalakrishnan

SL

REST, An Indicator of Poor Prognosis is a Novel Therapeutic Target for Medulloblastoma

11:20

11:40

a.m.

Vannina Lorenzi

SL

Cellular Effects Induced by Cistus Ladaniferus Essential Oil and its Chromatographic Fractions on the Multi-drug Resistant Enterobacter Aerogenes EA289 Strain

 

11:30

12:00

 noon

Kazuyuki Yoshizaki

IL

Expansion of Therapy with an Anti-IL-6R Antibody, Tocilizumab, in Chronic Inflammatory Disease Based on the Pathogenic Analysis of IL-6

 

11:30

12:00

noon

Thierry Langer

IL

Pharmacophores and Their Efficient Use for Ligand Profiling

 

11:40

12:00

noon

Beata Sperlagh

SL

P2Y12 Receptor Antagonists: A New Approach for the Treatment of Inflammatory and Neuropathic Pain

11:40

12:00

noon

Ana Ramirez de Molina

SL

Rosemary Extract as an Adjuvant Agent to Overcome Chemoresistance of Cancer Cells

 

 

 

 

 

12:00

12:20

p.m.

Prakash Nagarkatti

SL

Aryl Hydrocarbon Receptor (AhR) Ligands as Novel Drugs in the Treatment of Autoimmune Diseases Target Signaling Pathways

12:00

12:30

p.m.

Erik Van der Eycken

IL

Microwaves in the Synthesis of Medium-sized Ring Drug Candidates

12:00

12:20

p.m.

Laila Kudsiova

SL

Delivery of Anionic Versus Cationic Lipopolyplexes to the Brain by Convection Enhance Delivery (CED) for the Treatment of Dementias

12:00

12:20

p.m.

Tamar Sanikidze

SL

Citrus Extract as an Effective Remedy for the Correction of Metabolic Syndrome

12:20

12:40

p.m.

Mitzi Nagarkatti

SL

Dietary Indoles are Novel Immunosuppressive Agents Against Inflammatory Diseases which Act by Modulating Epigenetic Regulation and miRNA Expression in T Cells

 

12:30

1:00

p.m.

Jin U. Kang

IL

Real-time 3-D Fourier-domain Optical Coherence Tomography Video Image Guided Microsurgeries

 

 

12:20

12:40

p.m.

W. Gibson Wood

SL

Regulation of the HMG-CoA Reductase Pathway in Alzheimer's Disease: Specific Targeting of Isoprenoids but not Cholesterol

 

12:20

12:50

p.m.

Thomas Baum

IL

Magnetic Resonance Imaging Based Cartilage T2 Relaxation Time Measurements as Non-invasive Biomarker for Knee Osteoarthritis

 

12:40

1:00

p.m.

Mohammad Sharif Sharifi

SL

Treatment of Urticaria with Wet Cupping

1:00

1:20

p.m.

Nidhi P. Sapkal

SL

Design, Development, Scale Up and Validation of a Convenient and Cost Effective Granulation Technology for the Formulation of Tablets Using Conventional Excipients

 

12:40

1:00

p.m.

James W. Lillard, Jr.

SL

XPCLAD Nanoreformulation of Cisplatin for Prostate Cancer

 

12:50

1:20

p.m.

Marc Arnold

IL

Discovery and Development of Universal Fc Binders for Antibody Purification

 

1:00

1:20

p.m.

Sung Mun Lee

SL

Novel Oral Drug Delivery System for Inflammatory Diseases

1:20

1:40

p.m.

Sergey A. Tarasov

SL

Novel Opportunity for Pharmacological Regulation of Endogeneous Targets by Antibodies in Release Active Form

 

1:00

1:20

p.m.

Taj Ur Rehman

SL

A Sunlight-induced Method for Rapid Biosynthesis of Silver Nanoparticles Using an Andrachnea Chordifolia Ethanol Extract

1:20

1:40

p.m.

 

Azita Azarkeivan

SL

Evaluation of Gastric Side Effects of New Form of Deferiprone, (L1; Enteric Coated)

 

1:20

1:40

p.m.

 

Azza Altawashi

SL

CC2D1A Links cAMP Signaling to Non-syndromic Mental Retardation

 

1:40

2:00

p.m.

Carmay Lim

SL

Novel Zn Finger Drug Targets

 

LUNCH BREAK: 2:00 – 3:00 p.m.

POSTER SESSION: 3:00 – 4:25 p.m.

 

Poster Session: 3:00 – 4:25 p.m.

Departure for Gala Dinner at 4:30 p.m.

The buses will leave for hotels at 9:30 p.m.

 

[Back To Top]

DAY 4: Thursday, February 21, 2013

JOINT PLENARY SESSION

Time

Chairman: Taleb-Al-Tel

Co-Chairman: R. Kumar

Speaker

Title

9:00
9:45

a.m.

Location: Auditorium

Muhammad Iqbal Choudhary

PL

Discovery of Anti-Infective and Multi-drug Resistance Reversal Agents  

 

9:45

10:30

a.m.

Location: Auditorium

Debomoy K. Lahiri

PL

MicroRNA to Study Physiological Regulation of Gene Products Implicated in CNS Disorders: Discovery of Novel APP and BACE-specific MicroRNAs Important for Alzheimer's Disease

 

Locations

Lecture Hall 1

MPH 1

Top Floor: Health Science Building

Lecture Hall 2

MPH 2

Top Floor: Health Science Building

Lecture Hall 3

MPH 3

Top Floor: Health Science Building

Lecture Hall 4

MPH 4

Top Floor: Health Science Building

 

Chairman: V. Smirnov

Co-Chairman: J. Yu

Chairman:  A.F. Vanin

Co-Chairman:  L.  Torun

Chairman:  T. Langer

Co-Chairman: J.U. Kang

Chairman:  V. Lorenzi

Co-Chairman: C. Lim

10:35

10:55

a.m.

Evgenij Germanovich Skurikhin

SL

Antifibrotic Effects of Reserpine on Lung Fibrosis, Haematopoietic Stem Cells in the Pathogenesis of Pneumofibrosis

 

10:35

11:05

a.m.

Drazen Raucher

IL

Thermally Targeted Delivery of a c-Myc Inhibitory Peptide to Breast and Brain Tumors In vivo Using Elastin-like Polypeptide

10:35

11:05

a.m.

Don S. Richards

IL

Simultaneous Quantitative and Qualitative DMPK Measurements Using a Quadrupole-time-of-Flight Mass Spectrometer

 

10:35

11:05

a.m.

Felix-Martin Werner

IL

Therapeutic Options in the Treatment of Generalized Epilepsy According to a Neuronal Network

 

10:55

11:15

a.m.

Safa Fitouri

SL

Design, Synthesis and Biological Evaluation of some Triazole Schiff's Base Derivatives as Potentials Anti – Tubercular Agents

11:05

11:35

a.m.

Luc Van Hijfte

IL

Biophysical Technologies Applied to Fragment Based Drug Discovery: Discovery of a New Series of PIM1/3 Selective Kinase Inhibitors

 

11:05

11:25

a.m.

Alexey Kopylov

SL

Apta-miniLego for Thrombin Inhibitors: New Insights into Nano-module Construction

11:05

11:35

a.m.

Alan Prem Kumar

IL

The Key "Missing" Regulator and Therapeutic Target for NFkB-induced Metastasis in Human Breast Cancer

 

11:15

11:35

a.m.

Evgenij Germanovich Skurikhin

SL

Antifibrotic Properties of Pegylated Hyaluronidase in Pneumofibrosis.  Spiperone Increases the Effects of Pegylated Hyaluronidase

 

 

 

COFFEE BREAK: 11:30 – 12:00 noon

Locations

Lecture Hall 1

MPH 1

Top Floor: Health Science Building

Lecture Hall 2

MPH 2

Top Floor: Health Science Building

Lecture Hall 3

MPH 3

Top Floor: Health Science Building

Lecture Hall 4

MPH 4

Top Floor: Health Science Building

 

Chairman:  W.G. Wood

Co-Chairman:  B.  Sperlagh

Chairman:  Q. Timour

Co-Chairman:  S.A. Siddiqi

Chairman: D.  Raucher

Co-Chairman:  L.V.  Hijfte

Chairman:  M. Seki

Co-Chairman: S.M. Adekenov

12:00

12:30

p.m.

Debomoy K. Lahiri

IL

Neuroprotective and Neuropreservative Effects of Nutraceuticals in Neuronal Cultures: Potential Preventive and Therapeutic Strategies in Alzheimer's Disease (AD)

 

12:00

12:30

p.m.

Yulia Komarova

IL

End Binding Protein 3: A Novel Target for Treating Acute Lung Injury

12:00

12:30

p.m.

Jean-Paul Renaud

IL

Noncovalent Mass Spectrometry Combined with X-ray Crystallography and Other Biophysical Techniques for Drug Discovery

12:00

12:30

p.m.

Gerhard Muller

IL

Novel Kinase Inhibitors with Pre-engineered Slow Off-rates

 

12:30

12:50

p.m.

Nadia Mohamed Said Arafa

SL

Prophylactic Effect of Hypericum Perforatum Extract in Scopolamine Rat Model of Cognitive Dysfunction

 

12:30

12:50

p.m.

Dipak P. Ramji

SL

Signalling Pathways Underlying Interferon-ν Actions in Atherosclerosis

 

12:30

1:00

p.m.

Anatoly F. Vanin

IL

Dinitrosyl Iron Complexes With Thiol-Containing Ligands as a Base for New-generation Drugs

 

12:30

1:00

p.m.

Taleb H. Al-Tel

IL

Single Building Block Architecture: Toward the Design and Discovery of Novel and Tissue Selective Anticancer Drug Leads

 

12:50

1:10

p.m.

Youssef Sari

SL

Ceftriaxone Attenuates Alcohol Intake Through Regulatory Effects of Both GLT1 and ENT1 in Central Reward Brain Regions in Alcohol-preferring Rats

 

 

12:50

1:10

p.m.

InKyeom Kim

SL

Recruitment of Specificity Protein 1 by CpG Hypomethylation Upregulates Na+-K+-2CI- Contransporter 1 in Hypertensive Rats.

 

 

1:00

1:20

p.m.

Lokman Torun

SL

New Aryl Substituted Oxatropenes: Synthesis and Biological Profiles

1:00

1:20

p.m.

Zehra Naz

SL

Is Fructose an Ideal Sweetening Agent?

1:10

1:30

p.m.

Felix-Martin Werner

SL

 Novel Therapeutic Options in Major Depression According to a Neuronal Network

 

 

1:10

1:30

p.m.

Vera A. Spiridonova

SL

DNA Aptamers as Therapeutic Agents

1:20

1:40

p.m.

 Asaad Khalid Ahmed

SL

Discovery of TB Drugs from African Medicinal Plants The Road to EI Dorado

1:20

1:40

p.m.

Gerhard Muller

SL

Privileged Structures in Medicinal Chemistry Unlocking the PDE, GPCR, and Epigenetic Target Space

 

 

1:30

1:50
p.m.

Harish C. Pant

SL

Role of Topographic Phosphorylation in the Nervous System

 

1:30

1:50

p.m.

Tamar Sanikidze

SL

Antiatherogenic Effectiveness of Georgian Red Grape

 

1:40

2:00

p.m.

Helmut Durchschlag

SL

Development of Anti-Radiation Drugs

LUNCH BREAK: 2:00 – 3:00 p.m.

POSTER PRESENTATIONS: 3:00 – 4:00 p.m.

CASH PRIZE ANNOUNCEMENT FOR THREE BEST POSTERS: 4:00 p.m.

POSTER PRESENTER'S PRESENCE IS ESSENTIAL TO RECEIVE THE CASH AWARD AND CERTIFICATE OF MERIT

 

Departure for City Tour at 4:15 p.m.

 

IMPORTANT:  The buses will leave daily from all Hotels at 8:15 a.m. for the conference venue. 

 

PL: Plenary Lecture

JL: Julphar Lecture

IL: Invited Lecture

SL: Session Lecture

[Back To Top]

 

Conferences & Trade shows [Webmaster]   Copyright © 2012 5th International Conference on Drug Discovery & Therapy